The upregulation of A2AR in both neurons and glial cells contributes to network hyperexcitability and sustained neuronal damage, central to the development of drug-resistant epilepsy and a heightened risk of SUDEP [206,246,247]. Here, ADORA2A is linked to epilepsy.